Matrix-Bio is a diagnostics service company focused on developing blood based cancer diagnostics using a proprietary and patent-pending Metabolite-Profiling platform technology. Within the next year, MBI will offer a simple blood test for breast cancer recurrence that is significantly more accurate than current monitoring assays. Matrix-Bio is also developing early detection tests to complement mammography, and for colon and esophageal cancers.